D Sources, D Extraction, D Synthesis - Ann Intern Med, 2001 - Am Coll Physicians Purpose: Evidence-based medicine guidelines based on veno- graphic end points
recommend in-hospital prophylaxis with low- molecular-weight heparin (LMWH) in
patients having elective hip surgery. Emerging data suggest that ... Cited by 180 - Related articles - BL Direct - All 6 versions
JW Eikelboom, DJ Quinlan, JD Douketis - The Lancet, 2001 - Elsevier Nine studies met our inclusion criteria (3999 patients), eight with low
molecular weight heparin, and one with unfractionated heparin. Extended-duration
prophylaxis for 30–42 days significantly reduced the frequency of ... Cited by 269 - Related articles - BL Direct - All 6 versions
AT Cohen, CS Bailey, R Alikhan, DJ Cooper - Thrombosis and haemostasis, 2001 - cat.inist.fr Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic
venous thromboembolism following lower limb arthroplasty: a meta-analysis. ... Cited by 65 - Related articles - BL Direct - All 2 versions
- ►jbjs.org [PDF] PC Comp, TE Spiro, RJ Friedman, TL … - The Journal of Bone and Joint Surgery, 2001 - JBJS Theodore E. Spiro, MD Cardiovascular Therapeutic Area, European Operations Site,
E2/309, Aventis Pharma, 20 Avenue Raymond Aron, 92160 Antony, France. E-mail
address: theodore.spiro@aventis.com. Please address correspondence and ... Cited by 101 - Related articles - BL Direct - All 5 versions
MR Lassen, LC Borris, BS Anderson, HP Jensen … - Thrombosis research, 1998 - ncbi.nlm.nih.gov The aim of this study was to compare the efficacy and safety of prolonged (35
days) thromboprophylaxis with a standard length (7 days) regimen of a low
molecular weight heparin in patients undergoing total hip arthroplasty. The ... Cited by 133 - Related articles - BL Direct - All 3 versions
A Planes, N Vochelle, JY Darmon, M Fagola, … - Lancet, 1996 - ncbi.nlm.nih.gov BACKGROUND: The risk of deep-vein thrombosis (DVT) and pulmonary embolism after
total hip replacement (THR) surgery may persist after hospital discharge, but
the extent of the risk is not known. We carried out a single-centre, ... Cited by 307 - Related articles - BL Direct - All 4 versions
- ►ejbjs.org CW COLWELL, DK COLLIS, R Paulson, J … - The Journal of Bone and Joint Surgery, 1999 - JBJS Background: Venous thromboembolic disease in the form of deep venous thrombosis
and pulmonary embolism is a major risk after a total hip arthroplasty.
Enoxaparin, a low-molecular-weight heparin, has been shown to reduce the ... Cited by 184 - Related articles - BL Direct - All 7 versions
RD Hull, GF Pineo, C Francis, D Bergqvist, C … - Archives of Internal Medicine, 2000 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 141 - Related articles - BL Direct - All 5 versions
D Bergqvist, G Benoni, O Bjorgell, H Fredin, … - New England Journal of Medicine, 1996 - content.nejm.org Results Venography was adequate in 116 patients in the placebo group and 117 in
the enoxaparin group. We observed 43 episodes of deep-vein thrombosis and 2
episodes of pulmonary embolism in the placebo group, but only 21 episodes ... Cited by 316 - Related articles - BL Direct - All 5 versions
M O'Donnell, LA Linkins, C Kearon, J Julian, J … - Archives of Internal Medicine, 2003 - Am Med Assoc Background Numerous trials and meta-analyses have shown that extended
out-of-hospital prophylaxis with low-molecular-weight heparin reduces
asymptomatic and symptomatic venous thromboembolism after total hip ... Cited by 50 - Related articles - BL Direct - All 5 versions
